Addressing Key Challenges in Viral Hepatitis Management

Download All
Read about and listen to healthcare professional and patient perspectives on management challenges in viral hepatitis and practical strategies to address them, as well as global expert perspectives on key topics in viral hepatitis treatment and care with this program of ClinicalThought commentaries and audio podcasts.
Dominique Laurent Braun, MD
person default
Jacki Chen, PhD
person default
Julie Dang, PhD, MPH
person default
Ani Kardashian, MD
Takeshi Saito, MD, PhD
Stacey Trooskin, MD, PhD, MPH

ClinicalThought

By following simplified management guidelines, primary care professionals can easily diagnose and treat HCV, which can only help our patients engage in HCV treatment.

Stacey Trooskin, MD, PhD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 6, 2021 Expired: August 5, 2022

With only a minority of US patients with chronic HBV infection being tested for HDV coinfection, the most critical milestone for identifying patients with HDV is increasing HDV awareness among healthcare workers.

Takeshi Saito, MD, PhD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 20, 2021 Expired: August 19, 2022

Simplified approaches to HCV treatment help treat and cure HCV in more of our patients and take us closer to the goal of HCV elimination.

Stacey Trooskin, MD, PhD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 31, 2021 Expired: August 30, 2022

Approval of bulevirtide in Europe and promising clinical trial results with lonafarnib signal that new management options for patients with hepatitis delta are on the horizon.

Takeshi Saito, MD, PhD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: September 28, 2021 Expired: September 27, 2022

Community engagement and collaboration with healthcare systems can boost uptake of HBV screening and care.

person default Julie Dang, PhD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: November 18, 2021 Expired: November 17, 2022

My take on how social determinants of health influence liver disease prevalence, outcomes, and treatment access in the United States; how the COVID-19 pandemic has exacerbated these disparities; and what interventions are needed from healthcare professionals and institutions to address these health inequities.

person default Ani Kardashian, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: November 23, 2021 Expired: November 22, 2022

How I overcame barriers to receiving specialist treatment and care following my diagnosis with chronic HBV infection.

person default Jacki Chen, PhD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: December 9, 2021 Expired: December 8, 2022

A 3-pronged approach to HCV elimination in MSM patients with HIV and HCV: test, treat, and counsel.

Dominique Laurent Braun, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 10, 2022 Expired: January 9, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
AbbVie
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings